Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response

(2017) Melanie J. McCoy et al.   Oncotarget

Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer

(2017) Guoliang Yang et al.   Oncotarget

The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy

(2017) Hirokazu Shoji et al.   Oncotarget

Cellular immunity augmentation in mainstream oncologic therapy

(2017) Daohong Chen et al.   Cancer Biology & Medicine

Myeloid-derived suppressor cells and their role in pancreatic cancer

(2016) M Pergamo et al.   CANCER GENE THERAPY

Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma

(2016) Eishiro Mizukoshi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen

(2016) Emeric Limagne et al.   CANCER RESEARCH

Immunotherapy with methyl gallate, an inhibitor of Treg cell migration, enhances the anti-cancer effect of cisplatin therapy

(2016) Hyunseong Kim et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients

(2016) Athanasios Kotsakis et al.   Scientific Reports

The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy

(2016) Mario Roselli et al.   OncoImmunology

The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder

(2016) Alexander S. Baras et al.   OncoImmunology

Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors

(2016) Rikke B. Holmgaard et al.   EBioMedicine

St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists

(2015) M. Ignatiadis et al.   ANNALS OF ONCOLOGY

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer

(2015) M J McCoy et al.   BRITISH JOURNAL OF CANCER

Using chemo-drugs or irradiation to break immune tolerance and facilitate immunotherapy in solid cancer

(2015) Yawen Zheng et al.   CELLULAR IMMUNOLOGY

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

(2015) Douglas Marvel et al.   JOURNAL OF CLINICAL INVESTIGATION

Identification of a FOXP3+CD3+CD56+ population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma

(2015) Xiaofeng Li et al.   Scientific Reports

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

(2015) Mahiru Kawano et al.   Scientific Reports

Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy

(2014) Alessandra Romano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Chemotherapeutic Targeting of Cancer-Induced Immunosuppressive Cells

(2014) D. Alizadeh et al.   CANCER RESEARCH

Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion

(2014) Alessia Zoso et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer

(2014) Jinpu Yu et al.   JOURNAL OF IMMUNOLOGY

Accuracy and Reproducibility of HER2 Status in Breast Cancer Using Immunohistochemistry: A Quality Control Study in Tuscany Evaluating the Impact of Updated 2013 ASCO/CAP Recommendations

(2014) S. Bianchi et al.   PATHOLOGY & ONCOLOGY RESEARCH

Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer

(2013) J. Yu et al.   JOURNAL OF IMMUNOLOGY

Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T CellsIn Situand Lymph Node Metastasis

(2011) Jinpu Yu et al.   Clinical & Developmental Immunology

Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer

(2009) P.-Y. Pan et al.   CANCER RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER